查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386266

遺傳性視網膜疾病市場報告：2030 年趨勢、預測與競爭分析

Inherited Retinal Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

遺傳性視網膜疾病的趨勢與預測

2030年，全球遺傳性視網膜疾病市場預計將達到55億美元，2024年至2030年的年複合成長率為7.5%。該市場的主要促進因素是政府對 IRD 研究和新治療方法開發的資助增加、IRD 盛行率上升以及人們對 IRD 的認知不斷提高。全球遺傳性視網膜疾病 (IRD) 市場的未來看起來充滿希望，醫院、專科診所、門診手術中心和居家醫療市場都充滿機會。

遺傳性視網膜疾病市場洞察

Lucintel 預測，由於對遺傳性視網膜疾病早期診斷的需求不斷增加，診斷預計將在預測期內實現強勁成長。

由於醫院擁有資源和專業知識，可以為遺傳性視網膜疾病患者提供診斷、治療和復健等廣泛的服務，因此醫院將繼續成為該市場的最大細分市場。

由於其發達的醫療基礎設施，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球遺傳性視網膜疾病市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球遺傳性視網膜疾病市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球遺傳性視網膜疾病市場
    • 診斷
    • 治療
  • 按疾病類型分類的全球遺傳性視網膜疾病市場
    • 色素性視網膜炎
    • 斯塔加特病
    • 色盲
    • 錐桿營養不良
    • 脈絡膜血症
    • 肝臟先天性黑蒙
    • 黃斑部水腫
    • 其他
  • 以最終用途分類的全球遺傳性視網膜疾病市場
    • 醫院
    • 專科診所
    • 門診手術中心
    • 家庭保健
    • 其他
  • 按配銷通路分類的全球遺傳性視網膜疾病市場
    • 零售
    • 直接競標

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球遺傳性視網膜疾病市場（按地區）
  • 北美遺傳性視網膜疾病市場
  • 歐洲遺傳性視網膜疾病市場
  • 亞太地區遺傳性視網膜疾病市場
  • 其他區域遺傳性視網膜疾病市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球遺傳性視網膜疾病市場成長機會
    • 按疾病類型分類的全球遺傳性視網膜疾病市場成長機會
    • 全球遺傳性視網膜疾病市場成長機會（依最終用途）
    • 全球遺傳性視網膜疾病市場成長機會（按配銷通路）
    • 全球遺傳性視網膜疾病市場成長機會（按地區）
  • 全球遺傳性視網膜疾病市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球遺傳性視網膜疾病市場的產能擴張
    • 全球遺傳性視網膜疾病市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Spark Therapeutics
  • Novartis
  • Okuvision
  • Nidek
  • Invitae Corporation
  • Zeiss
  • Optos
簡介目錄

Inherited Retinal Disease Trends and Forecast

The future of the global inherited retinal disease (IRD) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

A more than 150-page report is developed to help in your business decisions.

Inherited Retinal Disease by Segment

The study includes a forecast for the global inherited retinal disease by type, disease type, end use, distribution channel, and region.

Inherited Retinal Disease Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnosis
  • Therapy

Inherited Retinal Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Retinitis Pigmentosa
  • Stargardt'S Disease
  • Achromatopsia
  • Cone-Rod Dystrophy
  • Choroideremia
  • Leber Congenital Amaurosis
  • Macular Edema
  • Others

Inherited Retinal Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Healthcare
  • Others

Inherited Retinal Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Sales
  • Direct Tender

Inherited Retinal Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Inherited Retinal Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inherited retinal disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inherited retinal disease companies profiled in this report include-

  • Spark Therapeutics
  • Novartis
  • Okuvision
  • Nidek
  • Invitae Corporation
  • Zeiss
  • Optos

Inherited Retinal Disease Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Within this market, hospital will remain the largest segment due to the presence of resources and expertise to provide a wide range of services for patients with inherited retinal diseases, including diagnosis, treatment, and rehabilitation.

North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Features of the Global Inherited Retinal Disease Market

Market Size Estimates: Inherited retinal disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inherited retinal disease market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).

Regional Analysis: Inherited retinal disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the inherited retinal disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inherited retinal disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the inherited retinal disease market size?

Answer: The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for inherited retinal disease market?

Answer: The global inherited retinal disease market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the inherited retinal disease market?

Answer: The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

Q4. What are the major segments for inherited retinal disease market?

Answer: The future of the inherited retinal disease market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.

Q5. Who are the key inherited retinal disease market companies?

Answer: Some of the key inherited retinal disease companies are as follows:

  • Spark Therapeutics
  • Novartis
  • Okuvision
  • Nidek
  • Invitae Corporation
  • Zeiss
  • Optos

Q6. Which inherited retinal disease market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Q7. In inherited retinal disease market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the inherited retinal disease market by type (diagnosis and therapy), disease type (retinitis pigmentosa, stargardt's disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (retail sales and direct tender), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inherited Retinal Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Inherited Retinal Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Inherited Retinal Disease Market by Type
    • 3.3.1: Diagnosis
    • 3.3.2: Therapy
  • 3.4: Global Inherited Retinal Disease Market by Disease Type
    • 3.4.1: Retinitis Pigmentosa
    • 3.4.2: Stargardt's Disease
    • 3.4.3: Achromatopsia
    • 3.4.4: Cone-Rod Dystrophy
    • 3.4.5: Choroideremia
    • 3.4.6: Leber Congenital Amaurosis
    • 3.4.7: Macular Edema
    • 3.4.8: Others
  • 3.5: Global Inherited Retinal Disease Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Home Healthcare
    • 3.5.5: Others
  • 3.6: Global Inherited Retinal Disease Market by Distribution Channel
    • 3.6.1: Retail Sales
    • 3.6.2: Direct Tender

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Inherited Retinal Disease Market by Region
  • 4.2: North American Inherited Retinal Disease Market
    • 4.2.2: North American Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.3: European Inherited Retinal Disease Market
    • 4.3.1: European Inherited Retinal Disease Market by Type: Diagnosis and Therapy
    • 4.3.2: European Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.4: APAC Inherited Retinal Disease Market
    • 4.4.1: APAC Inherited Retinal Disease Market by Type: Diagnosis and Therapy
    • 4.4.2: APAC Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.5: ROW Inherited Retinal Disease Market
    • 4.5.1: ROW Inherited Retinal Disease Market by Type: Diagnosis and Therapy
    • 4.5.2: ROW Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Inherited Retinal Disease Market by Type
    • 6.1.2: Growth Opportunities for the Global Inherited Retinal Disease Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Inherited Retinal Disease Market by End Use
    • 6.1.4: Growth Opportunities for the Global Inherited Retinal Disease Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Inherited Retinal Disease Market by Region
  • 6.2: Emerging Trends in the Global Inherited Retinal Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Inherited Retinal Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inherited Retinal Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Spark Therapeutics
  • 7.2: Novartis
  • 7.3: Okuvision
  • 7.4: Nidek
  • 7.5: Invitae Corporation
  • 7.6: Zeiss
  • 7.7: Optos